EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE

Aim. To evaluate the comparative efficacy of Rosivastatin (Rosart) and atorvastatin in patients with very high grade of cardiovascular risk (CVR), arterial hypertension (AH) and chronic ischemic heart disease (CHD) in outpatient practice.Material and methods. Totally, 2 groups studied, of patients w...

Full description

Bibliographic Details
Main Authors:	V. P. Mikhin, D. V. Nebieridze, N. M. Akhmedzhanov, Yu. A. Zhilyaeva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atherosclerosis dyslipidemia statins endothelial dysfunction vessel wall rigidity
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/277

Similar Items

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP
by: V. P. Mikhin, et al.
Published: (2016-12-01)

The role of statins in erectile dysfunction: a systematic review and meta-analysis
by: Xiang Cai, et al.
Published: (2014-06-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis
by: M. V. Klimushina, et al.
Published: (2016-11-01)

Cardiovascular events, diabetes and guidelines: the virtue of simplicity
by: Ricardo J. Esper, et al.
Published: (2019-03-01)

Treatment of endothelial dysfunction with Rosuvastatin in patients with psoriasis
by: Olena I. SARIAN, et al.
Published: (2019-03-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin
by: Nuntakorn Thongtang, et al.
Published: (2017-07-01)

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
by: E. V. Sayutina, et al.
Published: (2020-11-01)

Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits
by: S. A. Davitashvili, et al.
Published: (2021-03-01)

Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
by: Fabio S Pimenta, et al.
Published: (2018-08-01)

Factors for Enhancement of Intracranial Atherosclerosis in High Resolution Vessel Wall MRI in Ischemic Stroke Patients
by: Na-Eun Woo, et al.
Published: (2020-06-01)

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
by: Wang Z, et al.
Published: (2013-12-01)

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits
by: Cristóbal Flores-Castillo, et al.
Published: (2019-05-01)

Progress of research on dyslipidemia accompanied by nephrotic syndrome
by: Min Tao, et al.
Published: (2020-09-01)

THE INFLUENCE OF ATORVASTATIN AND ROSUVASTATIN IN ATHEROSCLEROSIS ON THE PARAMETERS OF CELLULAR IMMUNITY AND IN VITRO LEUCOCYTE ACTIVATION
by: A. Yu. Filatova, et al.
Published: (2018-09-01)

Hypolidemic therapy today. New challenges and opportunities of statines
by: V. P. Mikhin, et al.
Published: (2018-04-01)

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
by: Miao Hu, et al.
Published: (2012-07-01)

Randomized study FARVATER: Part II. Atorvastatin effects on endothelial function, vascular wall distensibility and stiffness
by: A. V. Susekov, et al.
Published: (2007-06-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Modern principles of atherogenic dyslipidemia management in special groups of patients
by: Marina G. Bubnova, et al.
Published: (2020-09-01)

Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases
by: Dzyak G.V., et al.
Published: (2013-12-01)

Low-density lipoprotein cholesterol lowering treatment: the current approach
by: Irina Crismaru, et al.
Published: (2020-05-01)

Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factor
by: Şule Apraş Bilgen, et al.
Published: (2018-07-01)

Endothelial function and its role in the formation of cardiovascular pathology in patients with rheumatoid arthritis
by: A A Tulichev, et al.
Published: (2019-06-01)

Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study
by: A.C. Barreto, et al.
Published: (2008-08-01)

PHARMACOLOGICAL EFFICIENCY OF STATINS AND L-NORVALIN AT AN ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION
by: Inna Ivlitskaya, et al.
Published: (2016-06-01)

LIPID DISTRESS-SYNDROME AND PROSPECTS OF ITS CORRECTION BY STATINES
by: Tatiana Denisyuk, et al.
Published: (2017-09-01)

Relationship between Automated Coronary Calcium Volumes and a Set of Manual Coronary Lumen Volume, Vessel Volume and Atheroma Volume in Japanese Diabetic Cohort
by: Sumit K. Banchhor, et al.
Published: (2017-06-01)

Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E
by: Chen-Yi Lin, et al.
Published: (1999-09-01)

Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats
by: V. G. Banzaraksheev
Published: (2016-05-01)

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects
by: Kim E, et al.
Published: (2019-11-01)

Stroke in a Patient With HIV Infection
by: Buse Rahime Hasırcı, et al.
Published: (2015-08-01)

Human Vascular Microphysiological Systems for Drug Screening
by: Fernandez, Cristina Elena
Published: (2016)

Rosuvastatin microcirculatory effects in patients with dyslipidemia and arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2006-08-01)

Evaluation of endothelial dysfunction and its improvement after cardiac rehabilitation
by: Angela Cozma, et al.
Published: (2018-12-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

CONCOMITANT USE OF STATINS AND S-(2-BORON-ETHYL)-L-CYSTEINE ARGINASE INHIBITOR TO CORRECT ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION
by: Tatiana Denisyuk, et al.
Published: (2015-12-01)

PHARMACOTHERAPEUTIC STRATEGIES FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH USE OF STATINES IN SYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE
by: Tatiana Denisyuk
Published: (2017-12-01)

Infectious vasculitis. The role in the organ pathology
by: N. V. Skripchenko, et al.
Published: (2014-09-01)

Cannot write session to /tmp/vufind_sessions/sess_554eb4p49k601rjq4m505esvd3